{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:17:03Z","timestamp":1772057823004,"version":"3.50.1"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Atherosclerotic cardiovascular disease (ASCVD) is a growing public health challenge in the Middle East, driven by increasing rates of obesity, diabetes, and hypertension. However, limited region-specific data exist on the distribution and impact of Standard Modifiable Risk Factors (SMuRFs) among affected individuals. Most available evidence is derived from Western populations, which may not reflect the unique demographic, cultural, and epidemiological profiles of Middle Eastern communities.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>This study aims to compare demographic profiles, clinical presentations, comorbidities, and pharmacologic management among Middle Eastern patients with ASCVD, stratified by SMuRF burden: SMuRF-less (no risk factors), 1\u20132 SMuRFs, and 3\u20134 SMuRFs. The goal is to identify clinically relevant differences across these groups and address the significant gap in region-specific data on ASCVD risk factors and outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Data were pooled from six established cardiovascular registries and the Jordan SMuRF-less patient study. Baseline characteristics, cardiovascular risk profiles, comorbidities, use of secondary prevention therapies, and one-year outcomes were analyzed across the three SMuRF categories.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among 5,540 patients, the group with 3\u20134 SMuRFs exhibited the highest prevalence of hypertension (88.9%), diabetes (35.4%), smoking (54.0%), and a family history of cardiovascular disease (39.3%). This group also showed increased rates of chronic kidney disease (7.3%) and heart failure (15.1%). Statin, aspirin, and beta-blocker use increased in parallel with SMuRF burden. Key lipid profiles deteriorated with increasing SMuRFs, with the highest LDL cholesterol observed in patients with 1\u20132 SMuRFs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study provides valuable insight into the clinical characteristics and management patterns of Middle Eastern patients with atherosclerotic cardiovascular disease (ASCVD), stratified according to the burden of standard modifiable risk factors (SMuRFs). An increased SMuRF burden was associated with a higher prevalence of comorbid conditions, including hypertension, diabetes mellitus, dyslipidemia, chronic kidney disease, and heart failure. Utilizing data from six regional registries, this study represents the first comprehensive, region-specific analysis of the role of modifiable risk factors in this population. The findings underscore the critical need for individualized, risk-based prevention and management strategies to mitigate the rising burden of ASCVD across the Middle East.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0332302","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T17:33:20Z","timestamp":1758562400000},"page":"e0332302","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stratifying atherosclerotic cardiovascular disease by SMuRF burden in a Middle-Eastern country: A multiregistry study of demographics, comorbidities, and therapeutic trends"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-6714","authenticated-orcid":true,"given":"Osama","family":"Alkouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Albikawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Rajeh","family":"Saifan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-6621","authenticated-orcid":true,"given":"Haitham","family":"Khatatbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Ababneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanoud","family":"Alobaidly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-1562","authenticated-orcid":true,"given":"Omar","family":"Qaladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-3315","authenticated-orcid":true,"given":"Abdulhafith","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Jarrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-7314","authenticated-orcid":true,"given":"Mohammad","family":"Abuadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Hammoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohannad E.","family":"AbuRuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-7883","authenticated-orcid":true,"given":"Fadwa","family":"Alhalaiqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-2642","authenticated-orcid":true,"given":"Nezam","family":"Al-Nsair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"pone.0332302.ref001","doi-asserted-by":"crossref","unstructured":"Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global trends in atherosclerotic cardiovascular disease. 2023.","DOI":"10.1016\/j.clinthera.2023.09.020"},{"issue":"4","key":"pone.0332302.ref002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7793\/jcad.28.22-00004","article-title":"Aortic Arch Calcification in Ungated Lung Computed Tomography Scans as Predictors of Atherosclerotic Cardiovascular Disease: Methodology and Reproducibility in a Multi-Ethnic Study of Atherosclerosis","volume":"28","author":"I Golub","year":"2022","journal-title":"J Coron Artery Dis"},{"issue":"6","key":"pone.0332302.ref003","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.3390\/ijms24065420","article-title":"Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease","volume":"24","author":"A Al Samarraie","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0332302.ref004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","article-title":"Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease","volume":"46","author":"S Barquera","year":"2015","journal-title":"Arch Med Res"},{"issue":"6","key":"pone.0332302.ref005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/HCO.0000000000001074","article-title":"Inclisiran and cardiovascular events: a comprehensive review of efficacy, safety, and future perspectives","volume":"38","author":"AA Mohamed","year":"2023","journal-title":"Curr Opin Cardiol"},{"issue":"10226","key":"pone.0332302.ref006","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"S Yusuf","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"pone.0332302.ref007","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13098-024-01524-4","article-title":"Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors","volume":"16","author":"X Zhang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"pone.0332302.ref008","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/CLEP.S457054","article-title":"Associations Between Estimated Pulse Wave Velocity and Five-Year All-Cause Mortality in Patients with Atherosclerotic Cardiovascular Disease with and without Standard Modifiable Risk Factors: Evidence From NHANES 1999-2016","volume":"16","author":"X Li","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"16","key":"pone.0332302.ref009","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.123.064345","article-title":"Prevalence of diabetes and cardiovascular risk in the Middle East and Africa: primary results of the PACT-MEA study","volume":"147","author":"S Verma","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"pone.0332302.ref010","article-title":"Profiling Cardiometabolic Health in Jordan: A Call to Action to Improve Cardiovascular Health","volume":"15","author":"K Sawalha","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"pone.0332302.ref011","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12889-024-18316-0","article-title":"The burden of cardiovascular diseases in Jordan: a longitudinal analysis from the global burden of disease study, 1990\u20132019","volume":"24","author":"YA Al-Ajlouni","year":"2024","journal-title":"BMC Public Health"},{"issue":"10226","key":"pone.0332302.ref012","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"S Yusuf","year":"2020","journal-title":"Lancet"},{"key":"pone.0332302.ref013","doi-asserted-by":"crossref","unstructured":"Zhang X. Prognostic Value of Serum Glycated Albumin in Acute Coronary Syndrome Patients Without Standard Modifiable Cardiovascular Risk Factors. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4550877\/v1","DOI":"10.21203\/rs.3.rs-4550877\/v1"},{"issue":"11","key":"pone.0332302.ref014","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41569-019-0202-5","article-title":"70-year legacy of the Framingham Heart Study","volume":"16","author":"C Andersson","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"pone.0332302.ref015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"PW Wilson","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"pone.0332302.ref016","doi-asserted-by":"crossref","first-page":"15996","DOI":"10.1038\/s41598-022-19801-5","article-title":"Risk of earlier atherosclerotic cardiovascular disease in women with low bone mineral density","volume":"12","author":"J Park","year":"2022","journal-title":"Sci Rep"},{"key":"pone.0332302.ref017","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.2663","article-title":"Cardiovascular risk in elderly persons without established atherosclerotic cardiovascular disease","volume":"44","author":"B Hudzik","year":"2023","journal-title":"EHJ"},{"issue":"2","key":"pone.0332302.ref018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005054","article-title":"Modifiable Risk Factors Versus Age on Developing High Predicted Cardiovascular Disease Risk in Blacks","volume":"6","author":"AP Bress","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"pone.0332302.ref019","doi-asserted-by":"crossref","unstructured":"Aldalal\u2019ah MM, Hamza I, Alqudah M, Khasawneh H, Alomari S, Alomari A. Absence of standard modifiable risk factors (SMuRF-less) among 5002 Middle Eastern patients with atherosclerotic cardiovascular disease: (Interim analysis from the Jo-SMuRF Study). 2024;150(Suppl_1):A4120131-A.","DOI":"10.1161\/circ.150.suppl_1.4120131"},{"issue":"13","key":"pone.0332302.ref020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2023.06.045","article-title":"Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review","volume":"82","author":"GA Figtree","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"pone.0332302.ref021","doi-asserted-by":"crossref","first-page":"101343","DOI":"10.1016\/j.cpcardiol.2022.101343","article-title":"Prevalence and Outcomes in STEMI Patients Without Standard Modifiable Cardiovascular Risk Factors: A National Inpatient Sample Analysis","volume":"47","author":"GR Shamaki","year":"2022","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"pone.0332302.ref022","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12916-022-02418-w","article-title":"Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry","volume":"20","author":"S Li","year":"2022","journal-title":"BMC Med"},{"issue":"10","key":"pone.0332302.ref023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034493","article-title":"Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry","volume":"13","author":"A Shiyovich","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"pone.0332302.ref024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/CLEP.S457054","article-title":"Associations Between Estimated Pulse Wave Velocity and Five-Year All-Cause Mortality in Patients with Atherosclerotic Cardiovascular Disease with and without Standard Modifiable Risk Factors: Evidence From NHANES 1999-2016","volume":"16","author":"X Li","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"14","key":"pone.0332302.ref025","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations","volume":"311","author":"P Muntner","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"pone.0332302.ref026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005676","article-title":"Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status","volume":"6","author":"LD Colantonio","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"pone.0332302.ref027","article-title":"Cardiovascular Health Score and Atherosclerotic Cardiovascular Disease in the Million Veteran Program","volume":"7","author":"X-MT Nguyen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"pone.0332302.ref028","doi-asserted-by":"crossref","unstructured":"Kong G, Chew N, Ng CH, Ho YJ, St A, Lim OZ, et al. Prognostic Outcomes in Acute Coronary Syndrome Patients Without Standard Modifiable Risk Factors: A Multi-Ethnic Study of 8680 Asian Patients. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-941766\/v1","DOI":"10.21203\/rs.3.rs-941766\/v1"},{"key":"pone.0332302.ref029","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2147\/TCRM.S67945","article-title":"Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease","volume":"10","author":"H Gonz\u00e1lez-Pacheco","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"17","key":"pone.0332302.ref030","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1177\/2047487317720287","article-title":"Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors","volume":"24","author":"ST Vernon","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"48","key":"pone.0332302.ref031","article-title":"Risk factors of cardiovascular and cerebrovascular diseases in young and middle-aged adults: A meta-analysis","volume":"101","author":"Y Wu","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0332302.ref032","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1995-705X.206206","article-title":"Outcomes of Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: The Primary Analysis of the First Jordanian PCI Registry","volume":"18","author":"IA Alhaddad","year":"2017","journal-title":"Heart Views"},{"issue":"1","key":"pone.0332302.ref033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1341","article-title":"Atherosclerotic Cardiovascular Disease Novel and Traditional Risk Factors in Middle Eastern Young Women. The ANCORS-YW Study","volume":"19","author":"AJ Hammoudeh","year":"2024","journal-title":"Glob Heart"},{"issue":"2","key":"pone.0332302.ref034","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_36_21","article-title":"Surviving a Decade or More after Coronary Revascularization in a Middle Eastern Population: The Impact of Diabetes Mellitus","volume":"23","author":"IA Alhaddad","year":"2022","journal-title":"Heart Views"},{"key":"pone.0332302.ref035","first-page":"4240999","article-title":"One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study","volume":"2022","author":"A Hammoudeh","year":"2022","journal-title":"Int J Vasc Med"},{"key":"pone.0332302.ref036","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.amsu.2020.12.036","article-title":"Statin eligibility based on the ACC\/AHA guidelines among Middle Eastern patients with diabetes mellitus presenting with acute myocardial infarction","volume":"61","author":"MI Jarrah","year":"2020","journal-title":"Ann Med Surg (Lond)"},{"issue":"4","key":"pone.0332302.ref037","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.31083\/j.rcm2204175","article-title":"Acute cardiovascular events triggered by the COVID-19 pandemic-related stress in non-infected individuals. The Jordan COVID-19 Acute Cardiovascular Events (JoCORE) study","volume":"22","author":"AJ Hammoudeh","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"pone.0332302.ref038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/VHRM.S499355","article-title":"Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study","volume":"21","author":"AJ Hammoudeh","year":"2025","journal-title":"Vasc Health Risk Manag"},{"issue":"14","key":"pone.0332302.ref039","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality","volume":"389","author":"Global Cardiovascular Risk Consortium","year":"2023","journal-title":"N Engl J Med"},{"issue":"21","key":"pone.0332302.ref040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013296","article-title":"ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?","volume":"8","author":"ST Vernon","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"pone.0332302.ref041","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027851","article-title":"Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance","volume":"12","author":"ZS Chunawala","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"pone.0332302.ref042","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jcin.2022.03.036","article-title":"Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors","volume":"15","author":"GA Figtree","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"pone.0332302.ref043","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.2147\/IJGM.S330142","article-title":"Relationship of Noninvasive Assessment of Arterial Stiffness with 10-Year Atherosclerotic Cardiovascular Disease (ASCVD) Risk in a General Middle-Age and Elderly Population","volume":"14","author":"H Wang","year":"2021","journal-title":"Int J Gen Med"},{"issue":"4","key":"pone.0332302.ref044","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/1570161113666151026115921","article-title":"Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf","volume":"14","author":"I Al-Zakwani","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"issue":"22","key":"pone.0332302.ref045","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.120.050850","article-title":"Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries","volume":"143","author":"I Johansson","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"pone.0332302.ref046","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5144\/0256-4947.2012.9","article-title":"Baseline characteristics, management practices, and long-term outcomes of Middle Eastern patients in the Second Gulf Registry of Acute Coronary Events (Gulf RACE-2)","volume":"32","author":"KF Alhabib","year":"2012","journal-title":"Ann Saudi Med"},{"issue":"3","key":"pone.0332302.ref047","doi-asserted-by":"crossref","first-page":"14","DOI":"10.47604\/gjhs.2239","article-title":"Disaster Preparedness and Staff Well-being in Healthcare Staff: A Comprehensive Study in the UAE","volume":"8","author":"M Alsuwaidi","year":"2023","journal-title":"GJHS"},{"issue":"6","key":"pone.0332302.ref048","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/dom.15011","article-title":"A cross-sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT-MEA): Study design and rationale","volume":"25","author":"S Verma","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"pone.0332302.ref049","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: current features and implications","volume":"16","author":"D Zhao","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"pone.0332302.ref050","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(18)30031-7","article-title":"Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study","volume":"6","author":"A Murphy","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pone.0332302.ref051","article-title":"Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after COPD Hospitalization among Older Adults","author":"CL Mosher","year":"2023","journal-title":"medRxiv"},{"issue":"11","key":"pone.0332302.ref052","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1751-7176.2010.00371.x","article-title":"Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries","volume":"12","author":"J Al Suwaidi","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"pone.0332302.ref053","first-page":"101370","article-title":"Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention: An analysis from the e-Ultimaster registry","volume":"51","author":"O Kobo","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"6","key":"pone.0332302.ref054","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3122\/jabfm.2019.06.180313","article-title":"Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal","volume":"32","author":"Q Ngo-Metzger","year":"2019","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"pone.0332302.ref055","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.81","article-title":"Prevalence of diabetes and cardio-metabolic risk factors in young men in the United Arab Emirates: A cross-sectional national survey","volume":"2","author":"A Alzaabi","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"issue":"7","key":"pone.0332302.ref056","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1258\/shorts.2011.011019","article-title":"Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review","volume":"2","author":"L Alhyas","year":"2011","journal-title":"JRSM Short Rep"},{"key":"pone.0332302.ref057","doi-asserted-by":"crossref","unstructured":"Nabi Husain MGH, Brijeshkumar UR, Agarwal A, Manishbhai PD, Ghotra M, Panjiyar BK. Impact of Smoking Cessation on Cardiovascular Outcomes: A Systematic Review. 2023. https:\/\/doi.org\/10.1101\/2023.09.15.23295539","DOI":"10.1101\/2023.09.15.23295539"},{"issue":"2930","key":"pone.0332302.ref058","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30209","article-title":"Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study","volume":"152","author":"L Gilgien-D\u00e9n\u00e9r\u00e9az","year":"2022","journal-title":"Swiss Med Wkly"},{"issue":"11","key":"pone.0332302.ref059","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089149","article-title":"Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors","volume":"14","author":"R Rauf","year":"2024","journal-title":"BMJ Open"},{"issue":"10","key":"pone.0332302.ref060","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"GL Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"pone.0332302.ref061","volume":"66","author":"NS Anavekar","year":"2004","journal-title":"Cardiovascular risk in chronic kidney disease"},{"issue":"8","key":"pone.0332302.ref062","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/CIRCRESAHA.122.321748","article-title":"The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy","volume":"132","author":"K Schuett","year":"2023","journal-title":"Circ Res"},{"issue":"3","key":"pone.0332302.ref063","first-page":"287","article-title":"Genetic risk stratification: a paradigm shift in prevention of coronary artery disease","volume":"6","author":"R Roberts","year":"2021","journal-title":"BtTS"},{"issue":"9","key":"pone.0332302.ref064","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11883-023-01126-x","article-title":"The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to Know","volume":"25","author":"Y Manla","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"pone.0332302.ref065","volume-title":"Statin use for the primary prevention of cardiovascular disease in adults: preventive medication","author":"Force USPST","year":"2016"},{"issue":"1","key":"pone.0332302.ref066","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15420\/usc.2004.1.1.43","article-title":"Aspirin and Statins to Decrease Risks of Cardiovascular Disease \u2013 The Need for Wider Utilization","volume":"1","author":"CH Hennekens","year":"2004","journal-title":"US Cardiol"},{"issue":"1","key":"pone.0332302.ref067","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1038\/s41598-019-44641-1","article-title":"Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden","volume":"9","author":"A Sen","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0332302.ref068","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069770","article-title":"Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study","volume":"13","author":"M Leosdottir","year":"2023","journal-title":"BMJ Open"},{"key":"pone.0332302.ref069","volume-title":"Antiplatelet therapy: Mechanisms, indications, administration","author":"I Karunarathna","year":"2024"},{"issue":"1","key":"pone.0332302.ref070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacasi.2023.09.013","article-title":"Characteristics, Treatment, and In-Hospital Outcomes of Older Patients With STEMI Without Standard Modifiable Risk Factors","volume":"4","author":"G Zhao","year":"2023","journal-title":"JACC Asia"},{"issue":"16","key":"pone.0332302.ref071","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"DL Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0332302.ref072","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012356","article-title":"Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta-Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials","volume":"8","author":"D Giugliano","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"pone.0332302.ref073","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jebm.12312","article-title":"The impact of major dietary patterns on glycemic control, cardiovascular risk factors, and weight loss in patients with type 2 diabetes: A network meta-analysis","volume":"12","author":"B Pan","year":"2019","journal-title":"J Evid Based Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T17:33:30Z","timestamp":1758562410000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332302"}},"subtitle":[],"editor":[{"given":"Rizik M. H.","family":"Al-Sayyed","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":73,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332302","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}